The lysine degradation pathway is relevant to the neurometabolic process, and the disturbance of this pathway can lead to the occurrence of two severe neurometabolic disorders, pyridoxine-dependent epilepsy (PDE) and glutaric aciduria type 1 (GA1) [37]. The gene discussed is ALDH7A1; the disease is pyridoxine-dependent epilepsy.